Patents by Inventor Qingyan BO

Qingyan BO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230119360
    Abstract: The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of a therapeutic oligonucleotide targeting HBV and a TLR7 agonist for use in the treatment of a chronic hepatitis B patient.
    Type: Application
    Filed: June 17, 2022
    Publication date: April 20, 2023
    Inventors: Lu GAO, Yonghong ZHU, Søren OTTOSEN, Henrik MUELLER, Xue ZHOU, Julie Elisabeth Françoise BLAISING, Yuyan JIN, Qingyan BO, Gaurav TYAGI
  • Publication number: 20230044958
    Abstract: The present invention relates to methods of treating HBV, COVID-19 or SARS-CoV-2 infection in a human patient, wherein the methods comprise administration of a therapeutically effective amount of a TLR7 agonist, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 22, 2020
    Publication date: February 9, 2023
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Qingyan BO, Yuyan JIN, Gaurav TYAGI, Yonghong ZHU
  • Publication number: 20220370447
    Abstract: The present invention relates to method of treating HBV infection in a human patient, wherein the method comprises administration of a therapeutically effective amount of Compound (I), or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 18, 2020
    Publication date: November 24, 2022
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Qingyan BO, Valérie COSSON, Sheng FENG, Lu GAO, Yuyan JIN, Annabelle LEMENUEL, Miriam TRIYATNI, Xue ZHOU, Mingfen ZHU